BridgeMD
New treatment option for Acne Vulgaris
Official title Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.
ClinicalTrials.gov ID: NCT06501560
What this study is testing
What is GWAS?
GWAS is an investigational medicine, being studied as a potential treatment for acne vulgaris.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is a series of descriptive-analytic studies on genomic variants in the facial skin of patients with AV at the Dermatology and Venereology Polyclinic by determining the genetic profile by GWAS examination in AVB and analysing the genetic profile in AVB against differences in geographical location. The research design used was a cross-sectional design.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 17 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Males or females with AVB aged 17-21 years
- Both parents of complete people with or without a history of acne vulgaris aged up to 60 years
- Patients and parents are willing to participate in the study and sign informed consent.
You likely can't join if
- Patients who have other inflammatory or infectious diseases especially on the face
- Have genetic diseases or disorders
- Diagnosed with primary or secondary immunodeficiency diseases
- Using oral or systemic antibiotic, anti-inflammatory, retinoid or hormone therapy in the past month.
The study team makes the final eligibility decision.
Where it's taking place
- Jakarta Pusat, Jakarta Special Capital Region, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 17 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jakarta Pusat, Jakarta Special Capital Region, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.